Whipplewood Advisors, LLC Novartis Ag Transaction History
Whipplewood Advisors, LLC
- $176 Billion
- Q4 2024
A detailed history of Whipplewood Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 1,497 shares of NVS stock, worth $157,888. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,497Holding current value
$157,888% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,430Shares Held
133MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.27 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$854 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$737 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$609 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $227B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...